Virtual conference

Organon to Present at Cowen’s 42nd Annual Virtual Healthcare Conference | News

JERSEY CITY, NJ–(BUSINESS WIRE)–March 2, 2022–

Organon (NYSE: OGN), today announced that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, were set to participate in a fireside chat during the 42nd Annual Virtual Cowen Healthcare Conference on Wednesday, March 9, 2022 at 9:10 a.m. EST.

Investors, analysts, members of the media and the general public are invited to watch a live video webcast of the presentation at https://www.organon.com/investor-relations/events-and-presentations/.

About Organon

Organon is a global healthcare company created through a spin-off from Merck, (NYSE: MRK) known as MSD outside the United States and Canada, to focus on improving women’s health throughout their life. Organon has a portfolio of over 60 drugs and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and a stable established drug franchise, Organon’s products are generating strong cash flow that will support investments in innovation and growth opportunities future in women’s health. In addition, Organon seeks opportunities to collaborate with biopharmaceutical innovators seeking to commercialize their products by leveraging its scale and presence in fast-growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class business capabilities and approximately 9,500 employees headquartered in Jersey City, New Jersey.

For more information, visit https://www.organon.com and join us on LinkedIn and instagram.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220302005252/en/

CONTACT: Media contacts:

Karissa Peer

(614) 314-8094 Kate Vossen

(732) 675-8448Investor contacts:

Jennifer Haltchak

(201) 275-2711 Edward Barger

(267) 614-4669

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: OTHER HEALTH RESEARCH GENERAL HEALTH PHARMACEUTICAL TEENAGE CONSUMERS OTHER CONSUMER SCIENCE WOMEN BIOTECHNOLOGY OTHER SCIENCE HEALTH

SOURCE: Organon & Co.

Copyright BusinessWire 2022.

PUBLISHED: 03/02/2022 07:00 / DISK: 03/02/2022 07:02

http://www.businesswire.com/news/home/20220302005252/en

Copyright BusinessWire 2022.